Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Acura - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Acura

Approved

STANDARD

Acura

DJM Grandeur Corporation🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 161aca1ee4560d4b
Company: DJM Grandeur Corporation
Type: Standard

Approval Details

Approval Id: 161aca1ee4560d4b
Drug Approval Philippines Name: Acura
Product Name: Acura
Registration Number: HRP-308
Brand Name: Acura
Generic Name: Methyl Salicylate + Camphor + Menthol + Eucalyptus Oil
Dosage Form: Liniment
Dosage Strength: 31.7 g/4.9 g/1.6 g/0.98 g per 100 mL
Manufacturer: DJM Grandeur Corporation
Trader: Zizmore Corporation
Issuance Date: 28 June 2022
Expiry Date: 22 March 2027
Classification: Household Remedy (HR)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

161aca1ee4560d4b

Type

Standard

Back to Philippines FDA Approvals